Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats. - Wikidata - awgldk - TriplyDB

Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats.

Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats.

http://www.wikidata.org/entity/Q37320191

about

Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus.

P2860

Q54209804-06921378-29F7-4A10-A954-4A4E2DBE1814

P2860

Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats.

http://www.wikidata.org/entity/Q37320191

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 August 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Intranasal nanoemulsion-based ...... iral challenge in cotton rats.

@en

Intranasal nanoemulsion-based ...... iral challenge in cotton rats.

@nl

type

label

Intranasal nanoemulsion-based ...... iral challenge in cotton rats.

@en

Intranasal nanoemulsion-based ...... iral challenge in cotton rats.

@nl

prefLabel

Intranasal nanoemulsion-based ...... iral challenge in cotton rats.

@en

Intranasal nanoemulsion-based ...... iral challenge in cotton rats.

@nl

P1433

Q37320191-0E60DACA-C96C-4AD0-BADD-CA0D347CE59E

P1476

Q37320191-01475A6C-8E46-46C7-AD16-9CD62156948B

P2093

Q37320191-148F9CDA-26E9-40D1-BAA3-F96547FA7EE5

Q37320191-293A0BFF-C844-4423-A693-53A16EBB3AFE

Q37320191-2B5221CD-F4AD-4FD1-85FF-566D10CF66EC

Q37320191-2D672BA5-EEC3-4258-9324-20548E70EC34

Q37320191-45370136-83DB-4907-8369-EF9A048AA91A

Q37320191-4B44A3B5-3CE3-4FF5-BBC8-6A1552155086

Q37320191-57793B6F-1F20-41EE-BE09-776DD5993286

Q37320191-5BC0ED33-52F7-464E-936B-53C76CF31881

Q37320191-666D8ED5-CB35-4C84-9F56-D6C4CFCE5924

Q37320191-771F7CE5-4D3B-49D4-A3ED-9D97B8B0628B

P2860

Q37320191-0E1B7F13-F99F-4E1F-A2B0-45A18B6559BD

Q37320191-1091329E-E88D-459C-A06D-5351F8F2FAAB

Q37320191-118BDF46-2EF0-4291-83F0-1E1C75245753

Q37320191-15EFD5B2-9844-4118-9A3D-50C91CAD09FE

Q37320191-17D7B905-BC50-4C37-9C40-3DB06530F81E

Q37320191-1FBDF0C2-B0C6-4B1F-B28D-5E414785AE42

Q37320191-26283491-C4BE-41F4-B855-8C612019E83A

Q37320191-437048A9-1FB1-4128-9C29-8C96C4E88196

Q37320191-509F53F8-1C9F-4CB4-B828-BA4D9814F768

Q37320191-54AFED58-7295-40AD-88FB-C83DFA2DE5F5

P304

Q37320191-61007CE6-3FC1-4CE4-AAE1-022B632E7903

P31

Q37320191-40BC8560-D34C-447A-8FB6-3C6BF33BB76B

P356

Q37320191-64365D86-9C4D-4579-904D-CCAD3766E423

P433

Q37320191-CC0FF7F5-F7C5-4A0D-83FF-2629D92F6E52

P478

Q37320191-C7E7369E-717A-42C0-BAD6-3620C442C3F2

P577

Q37320191-6D25C0EE-42BC-4045-8721-5D010E3E5B11

P5875

Q37320191-18D018E3-2666-4ECF-A620-E51CEE0F8313

P698

Q37320191-3BF25D1B-BE13-49BE-B782-187C97DFA0D6

P932

Q37320191-AF5DA4CE-A944-4C65-8C6F-2C211FBEFD47

P356

21645515.2015.1075680

P1433

Human Vaccines & Immunotherapeutics

P1476

Intranasal nanoemulsion-based ...... iral challenge in cotton rats.

@en

P2093

Ali Fattom

http://www.w3.org/2001/XMLSchema#string

Carrie-Anne Malinczak

http://www.w3.org/2001/XMLSchema#string

James R Baker

http://www.w3.org/2001/XMLSchema#string

Jeffrey J Landers

http://www.w3.org/2001/XMLSchema#string

Jennifer Sun

http://www.w3.org/2001/XMLSchema#string

Jessica J O'Konek

http://www.w3.org/2001/XMLSchema#string

Jessie Pannu

http://www.w3.org/2001/XMLSchema#string

Nicholas W Lukacs

http://www.w3.org/2001/XMLSchema#string

Paul E Makidon

http://www.w3.org/2001/XMLSchema#string

Susan Ciotti

http://www.w3.org/2001/XMLSchema#string

P2860

A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease

Diversifying animal models: the use of hispid cotton rats (Sigmodon hispidus) in infectious diseases

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine

Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge

Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine

Formulation and characterization of nanoemulsion intranasal adjuvants: effects of surfactant composition on mucoadhesion and immunogenicity.

Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism.

Intranasal immunization with W 80 5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model.

Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV.

P304

2904-2912

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2015.1075680

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281310981

http://www.w3.org/2001/XMLSchema#string

P698

26307915

http://www.w3.org/2001/XMLSchema#string

P932

5054793

http://www.w3.org/2001/XMLSchema#string